Literature DB >> 7361663

Atrial flutter. I. Electrophysiologic substrates and modes of initiation and termination.

R M Watson, M E Josephson.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7361663     DOI： 10.1016/0002-9149(80)90115-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  12 in total

1.  Effects of high-frequency atrial pacing in atypical atrial flutter and atrial fibrillation.

Authors:  I Giorgberidze; S Saksena; L Mongeon; R Mehra; R B Krol; A N Munsif; P Mathew
Journal:  J Interv Card Electrophysiol       Date:  1997-09       Impact factor: 1.900

2.  Inferior vena cava-tricuspid annulus isthmus is a critical site of unidirectional block during the induction of common atrial flutter.

Authors:  H Poty; F Anselme; N Saoudi
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

3.  Atrial flutter: A smoking gun for atrial fibrillation.

Authors:  Javier E Banchs
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-17

4.  Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results.

Authors:  Ivan Cakulev; Antonio E Lacerda; Celeen M Khrestian; Kyungmoo Ryu; Arthur M Brown; Albert L Waldo
Journal:  J Cardiovasc Electrophysiol       Date:  2011-05-26

Review 5.  Atrial Fibrillation after Radiofrequency Ablation of Type I Atrial Flutter.

Authors:  Chan-Il Park; Pacale Gentil-Baron; Dipen Shah
Journal:  J Atr Fibrillation       Date:  2013-08-31

6.  Early versus late atrial fibrillation after atrial flutter ablation.

Authors:  Emmanuel Loutrianakis; Tawfik Barakat; Brian Olshansky
Journal:  J Interv Card Electrophysiol       Date:  2002-06       Impact factor: 1.900

7.  Effect of intravenous flecainide on atrial vulnerability in man.

Authors:  T Pop; N Treese; J C Kang; T Meinertz; W Kasper
Journal:  Klin Wochenschr       Date:  1983-06-15

8.  Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators.

Authors:  S M Fitts; M R Hill; R Mehra; P Friedman; S Hammill; G N Kay; A Prakash; C Webb; S Saksena
Journal:  J Interv Card Electrophysiol       Date:  1998-06       Impact factor: 1.900

9.  Effect of intravenous flecainide on atrial vulnerability in man.

Authors:  T Pop; N Treese
Journal:  Drugs       Date:  1985       Impact factor: 9.546

10.  Atrial tachycardia in infants and children: electrocardiographic classification and its significance.

Authors:  A V Mehta; L L Ewing
Journal:  Pediatr Cardiol       Date:  1993-10       Impact factor: 1.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.